Aohua Endoscopy Completes RMB 300 Million Series D Financing to Advance Next-Gen Endoscopy Systems and Global Service Network

Recently, VCBeat (WeChat Official Account: vcbeat) has exclusively learned that Shanghai Aohua Endoscopy Co., Ltd. (“Aohua Endoscopy”) announced the completion of its RMB 300 million Series D financing round. The round was led by JF Capital, with participation from Legend Capital and Qiming Venture Partners.

Aohua Endoscopy has been highly active in the past two years, successfully acquiring several endoscopic diagnosis and treatment product companies both domestically and internationally. Regarding this round of financing, Aohua Endoscopy stated that it will focus on investing in the research and development of next-generation endoscopy systems and the establishment of a global service network. Gu Xiaozhou, CEO of the company, remarked, “The development of China’s endoscopy industry faces significant challenges and requires sustained effort. Aohua Endoscopy will continue to advance innovation in endoscopic diagnostic and therapeutic technologies with unwavering dedication.”

Endoscopes are devices that integrate multidisciplinary technologies, including optics, electronics, structural engineering, and materials science. They have broad clinical applications, continuously expanding therapeutic indications, and significant market potential. However, due to extremely high technical barriers, most domestic medical device companies remain unable to enter this field.

In recent years, through technology introduction and absorption as well as independent research and development, domestic brands represented by Aohua have significantly narrowed the gap with imported brands in terms of product performance. Their 1080p full-high-definition optical endoscopy systems have reached an industry-leading level, becoming another important piece of medical equipment to be exported overseas.

In the domestic market, domestically produced electronic gastroscope, colonoscope, bronchoscope, laparoscope, and related surgical instruments are gradually undergoing upgrades through the latest CMOS technology, breaking through from the traditional mid-to-low-end market into the high-end segment. As the country continues to promote the development of primary healthcare institutions, the new “tiered” referral policy will drive an increase in equipment procurement by these facilities, thereby boosting the market share of domestic endoscopes. The previous market landscape, which relied heavily on imported endoscopic equipment, has been disrupted, and import substitution is set to become the dominant theme of market changes in the endoscopy sector.

Shanghai Aohua Photoelectric Endoscope Co., Ltd., established in 1994, is a globally renowned manufacturer of endoscopes. Its product portfolio covers gastrointestinal endoscopes, respiratory endoscopes, nasopharyngolaryngoscopes, laparoscopes, and endoscopic diagnostic and therapeutic instruments. Aohua is committed to making endoscopic diagnosis and treatment more accessible and convenient, providing comprehensive endoscopic solutions for healthcare professionals worldwide.